In general, the main challenges of rare diseases in basic research are the rarity, heterogeneity and the complex mechanisms. Antibodies are widely regarded as useful research tools to understand the molecular mechanisms and develop new treatment and prevention strategies. Creative Biolabs provides a wide range of primary and secondary antibodies to support the study of the genetic and molecular mechanisms of rare diseases.
Related rare diseases are included below, but not limited to:
| Rare Disease | |
| • Acute myeloid leukemia (AML) | • Mad cow disease |
| • ADA-Deficient SCID | • Mucopolysaccharidosis I (Hurler syndrome) |
| • Biliary Tract Cancer | • Mucopolysaccharidosis II (Hunter syndrome) |
| • Crigler-Najjar syndrome | • Duchenne Muscular Dystrophy |
| • Cutaneous T-Cell Lymphoma | • Fabry disease |
| • Lamellar Ichthyosis | • Farber’s disease |
| • Leber hereditary optic neuropathy | • Focal Segmental Glomerulosclerosis (FSGS) |
| • Leukemia/Myelodysplastic Syndrome (MDS) | • Gaucher Type 1 |
| • Liver/Biliary/Pancreas cancer | • Hereditary Angioedema (HAE) |
| • Lymphoma, Non Hodgkin Lymphoma (NHL) | • Hunter Syndrome (Mucopolysaccharidosis II, MPS II) |
| • Mesothelioma | • Huntington’s disease |
| • Midgut Carcinoid Tumors | • Mucopolysaccharidosis I (MPS I) |
| • Niemann Pick Type C disease | • Niemann-Pick disease |
| • Positive Chronic Myelogenous Leukemia | • Neuroblastoma |
| • Prev. of acute graft vs host disease (aGvHD) | • Neuromyelitis Optica Spectrum Disorder (NMO) |
| • Retinitis pigmentosa (RP) | • Pheochromocytoma and Paraganglioma |
| • Scleroderma | • Pompe Disease |
| • Spinal Muscular Atrophy | • Sanfilippo syndrome (Mucopolysaccharidosis III, MPS-III) |
| • Urea Cycle Disorders | • Sarcoma |
| • Wilson's Disease | • Acromegaly |
| • Wiskott-Aldrich Syndrome | • Active systemic onset juvenile idiopathic arthritis |
| • Acute lymphoblastic leukemia (ALL) | • Amyotrophic lateral sclerosis |
| • Angelman syndrome | • Cystic fibrosis |
| • Arginase deficiency | • Duchenne muscular dystrophy |
| • Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) | • Gaucher's disease |
| • Sickle cell disease | • Growth hormone insensitivity syndrome |
| • Soft tissue sarcoma | • Hemophagocytic lymphohistiocytosis |
| • Thrombotic microangiopathy | • Idiopathic pulmonary fibrosis |
| • Vasculitis | • Idiopathic thrombocytopenic purpura |
| • Von Willebrand disease | • Kawasaki Disease |
| • Velocardiofacial syndrome, psychosis Lymphoma | • Lambert-Eaton myasthenic syndrome |
Creative Biolabs offers a comprehensive list of basic research antibodies for rare disease. Each antibody is backed with a 100% guarantee of high specificity, activity, performance and repeatability.
High purity: SEC-HPLC analysis ensures the purity of each antibody product is ≥90% or ≥95%, depending on customer requirements.
High specificity: we conduct antigen binding tests ensure that antibodies with high affinity antigen specificity are obtained.
Protocols for antibody manipulation: The WB experiment guidelines covers all experimental conditions during a WB experiment. Products are strictly verified, and the data is accurate and reliable.
Comprehensive characterization: Multiple species and application quality testing to ensure that each antibody is a rigorously screened, high-quality product.
For more detailed information about our antibodies, please feel free to contact us.
